HIFU Sonablate 500 Receives TGA Market Approval in Australia
5th Sep 2005, 16:34 GMT
THS Int'l the exclusive distributor for the advanced HIFU Sonablate 500 in Asia and Australia, announces that the Therapeutic Goods Administration in Australia has given full market approval to the Sonablate 500, which has been used for the minimally invasive treatment of prostate cancer.